B cell receptor specific for H5N1 influenza hemagglutinin and neuraminidase (H5N1 BCR)

The B cell receptor (BCR) specific for H5N1 influenza hemagglutinin (HA) and neuraminidase (NA) epitopes is a membrane-bound immunoglobulin complex that serves as the primary sensor for avian influenza antigens on B lymphocytes (UniProt, 2024). These receptors are composed of a ligand-binding antibody molecule associated with the CD79A and CD79B signaling subunits, which together mediate the transition from antigen recognition to immune activation (PubMed, 2021). In the context of H5N1, a highly pathogenic avian influenza (HPAI) virus, these BCRs are essential for generating a protective humoral response, particularly those targeting the conserved stem region of the HA protein (Nature, 2009). Therapeutic strategies involving this target primarily focus on vaccine-mediated stimulation to elicit high-affinity BCRs and the subsequent production of neutralizing antibodies (CDC, 2023). Additionally, the identification of specific BCR sequences from H5N1 survivors has enabled the development of monoclonal antibodies like CR6261 and F10, which serve as passive immunotherapies (Science, 2011). These antibodies mimic the BCR's ability to neutralize the virus by blocking viral entry or release (PLoS ONE, 2008). Monitoring the frequency and diversity of these BCRs serves as a critical biomarker for vaccine efficacy and pandemic preparedness (WHO, 2024).

Other names

H5N1-specific B-cell receptorAnti-H5N1 BCRH5N1 HA-specific BCRH5N1 NA-specific BCRInfluenza A H5N1-reactive B-cell receptor

Vaccines act as exogenous antigens that bind to and activate these BCRs to stimulate B cell differentiation into antibody-secreting plasma cells; monoclonal antibodies are derived from these BCRs to provide passive immunity by binding to and neutralizing viral particles.